Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Public authority · Germany
Industry association · Belgium
Declared costs: €1.5M+ a year · in the register since 2016
Medicinal products for human use · Re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
MedTech Europe · filed 26 Apr 2021 · source
As the association representing the medical technology sector, MedTech Europe welcomes the recognition in the inception impact assessment that pharma health solutions bring about technological advances, and the inclusion of the potential of the digital transformation of health and care.
German Environment Agency (Umweltbundesamt, UBA) · filed 27 Apr 2021 · source
The German Environment Agency (UBA) welcomes the opportunity given by the European Commission to comment on the inception impact assessment regarding the evaluation and revision of the general pharmaceutical legislation as part of the realisation of the Pharmaceutical Strategy.
German Environment Agency (Umweltbundesamt, UBA) · filed 12 Apr 2022 · source
UBA appreciates the initiative of streamlining the technical and scientific work through EU agencies by an omnibus regulation. Environmental safety data already assessed by one of the European agencies should be available for procedures under different EU regulations. This should also apply to environmental data from the veterinary and human pharmaceutical legislation.
MedTech Europe · filed 4 Mar 2024 · source
MedTech Europe, the European industry association representing manufacturers of medical technologies (medical devices and in vitro diagnostic medical devices- IVDs), takes the opportunity to share its views on the One Substance, One Assessment (OSOA) package of legislative proposals published on 7 December 2023.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.